menu search

Xrp news: sec v ripple recap as the november 9 countdown begins

Amid the SEC v Ripple lawsuit, Bill Hinman’s role and the Programmatic Sales ruling could take center stage ...

November 4, 2023, 12:58 am

The weekly bottom line: the fed’s door is still open

U.S. Highlights The Federal Reserve’s policy statement took center stage this week. As expected, the ...

November 4, 2023, 12:36 am

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Aligos therapeutics to host kol event to discuss alg-000184 phase 1, aasld late breaker data

November 16 Event to feature KOL perspective on Emerging HBV Therapies SOUTH SAN FRANCISCO, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) — Aligos Therapeu...

November 3, 2023, 8:30 pm

Wave life sciences third quarter 2023 financial results scheduled for november 9, 2023

CAMBRIDGE, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage <...

November 3, 2023, 8:05 pm

Cellectis: end of 2023 data readouts to boost car-t prospects

Preliminary data from two early-stage studies are going to be shown at the ASH 2023 conference, showcas...

November 3, 2023, 6:57 pm

Gbp/usd forecast: look weak, despite initial bounce

The GBP/USD embarked on a rallying journey during the initial stages of Thursday’s trading session, although the landscape remains marred by conside...

November 3, 2023, 6:44 pm

Gold breaks out of inside day: bullish momentum building

Amid strong upward movement, gold targets a breakout above the trend high, setting the stage for a poss...

November 3, 2023, 4:18 pm

Stocks stage comeback ahead of fed decision: what to do now

Stocks have bounced off the late October lows as we head into the historically bullish month of November. Markets are reacting favorably ahead of the ...

November 3, 2023, 2:32 pm

Quoin pharmaceuticals announces third quarter 2023 financial results and corporate update conference call to be held on thursday november 9th at 8:30 am et

ASHBURN, Va., Nov. 03, 2023 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical ...

November 3, 2023, 12:41 pm

Runway growth finance corp. announces fourth quarter dividend of $0.40 with $0.06 supplemental distribution

MENLO PARK, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leadin...

November 3, 2023, 12:30 pm

Longeveron to report third quarter 2023 results and provide corporate update on november 10, 2023

MIAMI, Nov. 03, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical ...

November 3, 2023, 12:00 pm

Why crispr therapeutics stock charged northward this week

Gene therapy has been on a roller-coaster ride since the first patient was treated 33 years ago. This slow-motion story took another turn this week af...

November 3, 2023, 9:56 am

Quoin pharmaceuticals announces third quarter 2023 financial results and corporate update conference call to be held on thursday november 9th at 8:30 am et

ASHBURN, Va., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical ...

November 3, 2023, 8:41 am

Sales rates key for housebuilders as persimmon and taylor wimpey update

Hopes that interest rates have peaked and with it mortgages have seen housebuilders stage a rally in re...

November 3, 2023, 8:15 am

Gold prices in pakistan experience notable dip

On the international stage, gold prices have witnessed a downtrend, with the current rate standing at $1,987 per ounce. It’s important to note that ...

November 3, 2023, 5:59 am

Thor energy increases interest in alford east project as sign of confidence

Thor Energy has increased its interest in the Alford East copper oxide project in South Australia to 80% from 51% after fulfilling ...

November 3, 2023, 3:54 am


Search within

Pages Search Results: